CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 400.05M | 311.71M | 214.30M | 121.48M | 82.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 400.05M | 311.71M | 214.30M | 121.48M | 82.55M |
| Cost of Revenue | 32.60M | 22.14M | 12.10M | 5.17M | 3.81M |
| Gross Profit | 367.45M | 289.57M | 202.21M | 116.32M | 78.74M |
| SG&A Expenses | 116.16M | 96.07M | 82.06M | 58.76M | 57.81M |
| Depreciation & Amortization | 24.07M | 13.82M | 3.73M | 156.00K | 156.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 196.18M | 151.37M | 110.35M | 72.17M | 68.08M |
| Operating Income | 203.87M | 160.34M | 103.95M | 49.32M | 14.47M |
| Income Before Tax | 185.02M | 150.02M | 107.03M | 51.68M | 17.18M |
| Income Tax Expenses | 4.01M | -13.04M | -55.47M | 521.30K | -200.00 |
| Earnings from Continuing Operations | 181.01 | 163.06 | 162.50 | 51.16 | 17.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 181.01M | 163.06M | 162.50M | 51.16M | 17.18M |
| EBIT | 203.87M | 160.34M | 103.95M | 49.32M | 14.47M |
| EBITDA | 228.80M | 174.89M | 108.20M | 49.85M | 14.92M |
| EPS Basic | 2.37 | 2.20 | 2.26 | 0.78 | 0.24 |
| Normalized Basic EPS | 1.66 | 1.35 | 0.95 | 0.49 | 0.15 |
| EPS Diluted | 2.13 | 2.00 | 2.06 | 0.75 | 0.22 |
| Normalized Diluted EPS | 1.43 | 1.20 | 0.88 | 0.47 | 0.14 |
| Average Basic Shares Outstanding | 302.21M | 287.94M | 270.61M | 253.51M | 243.20M |
| Average Diluted Shares Outstanding | 345.04M | 321.03M | 288.62M | 261.23M | 246.93M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |